AKUMS

Akums Drugs & Pharmaceuticals Limited (AKUMS) Q3 2026 Earnings Call Transcript

7 hours ago

Akums Drugs & Pharmaceuticals Limited (NSE: AKUMS) Q3 2026 Earnings Call dated Feb. 16, 2026 Corporate Participants: Sandeep Jain —…

Earnings Summary – Akums Drugs & Pharmaceuticals Reports 14.8% Revenue Growth in Q3 FY26 Results

4 days ago

Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS), a pharmaceutical contract development and manufacturing organization (CDMO) announced its third-quarter and nine-month…